GlassScriptPhysician profile
Shawn P Stachler
NPI 1831430818
$5,467.19
in general payments reported to CMS, 2019-2025
30 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,274 · 2020: $113 · 2021: $493 · 2022: $251 · 2023: $1,959 · 2024: $179 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,430 · Food and Beverage: $906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,429.52 |
| Food and Beverage | $905.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,908.06 | 2019-2024 | Blueprint Patient Specific Instrumentation, Triathlon, Champion |
| Medtronic USA, INC. | $1,072.59 | 2019 | |
| Alpha Orthopedic Systems | $824.29 | 2021-2023 | |
| Arthrex, INC. | $550.93 | 2021-2023 | |
| Smith+Nephew, INC. | $316.63 | 2019-2025 | Healicoil, Q-Fix, Pico |
| Pacira Pharmaceuticals Incorporated | $104.84 | 2021-2025 | Zilretta, Iovera |
| Depuy Synthes Sales INC. | $68.85 | 2022 | |
| Pacira Therapeutics, INC. | $66.15 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $61.59 | 2021-2023 | Xiaflex |
| Vertex Pharmaceuticals Incorporated | $49.27 | 2024-2025 | |
| Endo USA, INC. | $48.02 | 2024-2025 | Xiaflex |
| Heron Therapeutics, INC. | $46.07 | 2021-2022 | |
| Ossur Americas, INC. | $38.47 | 2025 | |
| Ethicon US, LLC | $33.13 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $27.49 | 2023 | Seglentis |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $24.72 | 2025 | Irrisept |
| Horizon Therapeutics Plc | $24.58 | 2020-2021 | |
| Orthofix Medical, INC. | $23.54 | 2021 | |
| Medartis INC. | $21.30 | 2024 | Aptus |
| Trevena, INC. | $21.03 | 2021 | |
| Djo, LLC | $20.57 | 2024 | Cmf |
| Fidia Pharma USA INC. | $19.94 | 2023 | Hymovis, Triluron |
| Abbott Laboratories | $17.98 | 2021 | |
| Sonex Health, INC. | $14.46 | 2025 | Sx-One Microknife |
| Avanos Medical | $14.41 | 2021 | |
| Si-Bone, INC. | $12.58 | 2021 | |
| Covidien LP | $11.60 | 2020 | |
| Heraeus Medical, LLC. | $10.32 | 2021 | |
| Kinex Medical Company LLC | $7.15 | 2020 | |
| Skeletal Dynamics INC | $6.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Stachler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.